» Articles » PMID: 15878491

Sputum Color As a Marker of Acute Bacterial Exacerbations of Chronic Obstructive Pulmonary Disease

Overview
Journal Respir Med
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2005 May 10
PMID 15878491
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

We analyzed 795 sputa from 315 patients (233 males, mean age 69.3+/-8.8 years, mean number of exacerbations 2.52/patient) with acute exacerbations of moderate-to-severe chronic obstructive pulmonary disease (COPD) (mean steady-state FEV1 42.5+/-7.8% of predicted). 581/795 sputa were considered adequate. Sputum was analyzed by a quali-quantitative colorimetric scale allowing both color distinction and color degree of intensity. Quantitative culture was then performed (threshold: >10(6)CFU/mL). Samples were distinguished in mucoid (145) and purulent (436) sputa. Absence of bacterial growth was observed in 22% and 5% of mucoid and purulent sputa, respectively. Among mucoid sputa, Gram positive bacterial growth occurred more commonly compared to Gram negative and Pseudomonas aeruginosa/Enterobacteriaceae (56%, 24%, 20%, respectively). In purulent sputa, Gram positives were found in 38% of cases, Gram negatives in 38%, and P. aeruginosa/Enterobacteriaceae in 24%. We evaluated whether functional impairment (FEV1) orientates as to the infectious etiology of exacerbations. Significant differences were observed in the distribution of pathogens. Gram negative and P. aeruginosa/Enterobacteriaceae were isolated more frequently in the sputum when FEV1 was <35%. Our study indicates that purulent sputum is strongly associated with bacterial growth in COPD exacerbations. Deepening sputum color (from yellowish to brownish) was associated with increased yield of Gram negative and P. aeruginosa/Enterobacteriaceae.

Citing Articles

Exacerbation in patients with stable COPD in China: analysis of a prospective, 52-week, nationwide, observational cohort study (REAL).

Yang T, Cai B, Cao B, Kang J, Wen F, Chen Y Ther Adv Respir Dis. 2023; 17:17534666231167353.

PMID: 37073797 PMC: 10126609. DOI: 10.1177/17534666231167353.


Incidence and profile of severe exacerbations of chronic obstructive pulmonary disease due to biomass smoke or tobacco.

Golpe R, Blanco-Cid N, Dacal-Rivas D, Martin-Robles I, Veiga I, Guzman-Peralta I Ann Thorac Med. 2022; 17(4):193-198.

PMID: 36387759 PMC: 9662078. DOI: 10.4103/atm.atm_155_22.


Development and Validation of a Multivariable Prediction Model to Identify Acute Exacerbation of COPD and Its Severity for COPD Management in China (DETECT Study): A Multicenter, Observational, Cross-Sectional Study.

Yin Y, Xu J, Cai S, Chen Y, Chen Y, Li M Int J Chron Obstruct Pulmon Dis. 2022; 17:2093-2106.

PMID: 36092968 PMC: 9462440. DOI: 10.2147/COPD.S363935.


Methods of Sputum and Mucus Assessment for Muco-Obstructive Lung Diseases in 2022: Time to "Unplug" from Our Daily Routine!.

Charriot J, Volpato M, Petit A, Vachier I, Bourdin A Cells. 2022; 11(5).

PMID: 35269434 PMC: 8909676. DOI: 10.3390/cells11050812.


Effectiveness of Xin Jia Xuan Bai Cheng Qi Decoction in treating acute exacerbation of chronic obstructive pulmonary disease: study protocol for a multicentre, randomised, controlled trial.

Jin J, Zhang H, Li D, Jing Y, Sun Z, Feng J BMJ Open. 2019; 9(11):e030249.

PMID: 31784433 PMC: 6924718. DOI: 10.1136/bmjopen-2019-030249.